← Open Payments lookup

PREM SHRESTHA: Open Payments

NPI 1780202077 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$754 in 42 payments from 12 companies in 2025. Trend: 2023 $903 · 2024 $2,145 · 2025 $754

Food & beverage: $675Education: $79
CompanyPaymentsAmount
Janssen Biotech, Inc.12$281
Aimmune Therapeutics, Inc.17$164
Madrigal Pharmaceuticals3$67
Gilead Sciences, Inc.2$43
Regeneron Healthcare Solutions, Inc.1$39
Ipsen Biopharmaceuticals, Inc1$26
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$24
Celltrion USA Inc.1$23
RedHill Biopharma Inc.1$23
Novo Nordisk Inc1$23

Products named: TREMFYA, ZENPEP, REZDIFFRA, DUPIXENT, IQIRVO, XIFAXAN, VEGZELMA, Talicia.

Industry payments across TX — which companies pay providers there.